Issue 18 – Manulife Beats to its Own Drum

Earnings season can be quite a hectic time for many companies. Speculation, headlines and surprising results can drastically move stock prices. This earnings season, we were particularly interested in Manulife’s (TSX: MFC) results as there has been a lot of talk lately regarding their long-term care (LTC) business and the new life insurance capital adequacy test or LICAT. Furthermore, Manulife’s stock price has been under pressure since January when GE reported losses of US$6.2 billion on its LTC business.

Continue Reading in PDF

All products and services of Palos Wealth Management Inc and Palos Management Inc. are only available for sale to residents of Canada, unless the laws of a foreign jurisdiction permit sales to its residents. The contents of this site should not be considered an offer to sell or a solicitation to buy products or services to any person in a jurisdiction where such offer or solicitation is considered unlawful.